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ABSTRACT 
Background: First, to use confirmatory factor analysis (CFA) to test a hypothesis that two 
factors (internalizing and externalizing) account for lifetime comorbid DSM-IV diagnoses 
among adults with Bipolar I (BPI) disorder. Second, to use confirmatory latent class analysis 
(CLCA) to test the hypothesis that four clinical subtypes are detectible: pure BPI; BPI plus 
internalizing disorders only; BPI plus externalizing disorders only; and BPI plus internalizing 
and externalizing disorders. 
Methods: A cohort of 699 multiplex BPI families, ascertained and assessed (1998-2003) by the 
NIMH Genetics Initiative Bipolar consortium: 1156 with BPI disorder (504 adult probands; 594 
first-degree relatives; and 58 more distant relatives) and 563 first-degree relatives without BPI. 
Best-estimate consensus DSM-IV diagnoses were based on structured interviews, family history, 
and medical records. MPLUS software was used for CFA and CLCA. 
Results: The two-factor CFA model fit the data very well, and could not be improved by adding 
or removing paths. The four-class CLCA model fit better than exploratory LCA models or post-
hoc-modified CLCA models. The two factors and four classes were associated with distinctive 
clinical course and severity variables, adjusted for proband gender. Comorbidity, especially more 
than one internalizing and/or externalizing disorder, was associated with a more severe and 
complicated course of illness. The four classes demonstrated significant familial aggregation, 
adjusted for gender and age of relatives.  
Conclusions: The BPI two-factor and four-cluster hypotheses demonstrated substantial 
confirmatory support. These models may be useful for subtyping BPI disorders, predicting 
course of illness, and refining the phenotype in genetic studies. 
Key words: bipolar disorder; subtypes; comorbidity; confirmatory factor analysis; confirmatory 
latent class analysis. 
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INTRODUCTION 
Bipolar (BP) affective disorder affects 0.5-1.6% of the U.S. adult population and is 
frequently chronically debilitating (Goodwin and Jamison, 1990; World Health Organization, 
2002). BP Type I (BPI) illness is highly heritable with up to 80% of risk determined by genetic 
factors (Gershon et al., 1987; McMahon et al., 2001; Nurnberger and Berrettini, 1998; Potash 
and DePaulo, 2000; Smoller and Finn, 2003; Tsuang and Faraone, 1990). The characterization of 
BPI subtypes of persons may be helpful for early detection and for understanding course of 
illness, neurobiology, and treatment response. Subtypes may be characterized by clinical 
variables, including patterns of comorbid psychiatric symptoms and disorders (Cassano et al., 
2009; Cassidy et al., 2008; Nurnberger, 2002). The creation of homogeneous BPI subgroups 
based on comorbid conditions has modestly improved the success of genetic mapping (Cheng et 
al., 2006; MacKinnon et al., 1998; MacQueen et al., 2005; Nurnberger, 2002; Payne et al., 2005; 
Saunders et al., 2009; Schulze and McMahon, 2003). For example, three subtypes of BPI, as 
defined by comorbidity, have provided some of the strongest evidence of linkage to genomic 
regions: comorbid panic disorder, comorbid psychotic symptoms, and pure BPI with low rates of 
comorbidity (MacQueen et al., 2005). A subtype of BPI characterized by comorbid anxiety 
disorders has been supported by cross-sectional, longitudinal and familial studies (Birmaher et 
al., 2002; Goodwin and Hamilton, 2002; Johnson et al., 2000; MacKinnon et al., 2002; 
Schurhoff et al., 2000; Wozniak et al., 2002). A BPI subtype characterized by high rates of 
comorbid drug and alcohol abuse or dependence (Nurnberger et al., 2007; Sonne and Brady, 
1999) has shown evidence for elevated genetic predisposition to substance use disorders 
(DelBello et al., 1999; Duffy et al., 1998; Feinman and Dunner, 1996; Gershon et al., 1982; 
Helzer and Winokur, 1974; Kendler et al., 1993; Maier and Merikangas, 1996; Morrison, 1974; 
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Morrison, 1975; Nurnberger et al., 2007; Strakowski and DelBello, 2000; Winokur et al., 1995; 
Winokur et al., 1996; Winokur et al., 1970). Finally, offspring of BPI patients (compared to 
controls) have higher rates of affective, anxiety, and externalizing disorders such as conduct 
disorder, oppositional disorder, and substance abuse (Chang et al., 2003; Chang et al., 2000; 
DelBello and Geller, 2001; Gershon et al., 1985; Lapalme et al., 1997; Nurnberger et al., 2011; 
Nurnberger et al., 1988; Todd et al., 1996). 
Factor analysis and cluster analysis are complementary methods for investigating BPI 
clinical subtypes. They determine, respectively, whether comorbid variables (e.g., symptoms or 
lifetime disorders) can be parsimoniously explained by a fewer number of factors (i.e., clusters 
of variables) and whether BPI persons can be subdivided into subgroups (i.e., clusters of 
persons). (see Supplementary Text, Section B). 
Factor analyses have been conducted on psychiatric lifetime disorders among community 
samples. For example, an internalizing and externalizing factor were found (Kessler et al., 2011). 
However, no published study has used a factor analysis, cluster analysis, or a latent cluster 
analysis (called latent class analysis; LCA) to explore or test hypotheses about the lifetime 
disorders comorbid with BPI.  
The first purpose of this paper is to disseminate the first published investigation of 
lifetime disorders (i.e., instead of symptoms) in a confirmatory test of a hypothesized factor 
analysis model among BPI individuals. Based on literature cited above, we hypothesized a two-
factor lifetime comorbidity model, specified before confirmatory factor analysis (CFA) was 
performed and then tested with CFA; in which internalizing and externalizing factors are 
correlated; and for which the internalizing factor explains correlations between anxiety, 
somatoform and eating disorders; and the externalizing factor explains correlations between 
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alcohol use, drug use, cluster B personality, impulse control, attention-deficit, and disruptive 
disorders. 
No published study has tested hypotheses about clinical subtypes, among BPI patients, by 
using a confirmatory approach to LCA, neither with symptoms nor disorders. Confirmatory LCA 
(CLCA) provides a powerful method to test and validate hypotheses about subgroups of persons 
with BPI (Finch and Bronk, 2011). 
Thus, the second, and primary, purpose of this paper was to provide a confirmatory test 
of a hypothesis about subgroups of BPI lifetime comorbid disorders, specified before CLCA was 
performed and then tested with CLCA. Based on literature cited above, we hypothesized four 
comorbidity subtypes of BPI patients: pure BPI without comorbidity, comorbidity with only 
internalizing disorders, comorbidity with only externalizing disorders, and comorbidity with both 
internalizing and externalizing disorders.  
 
METHODS      
Study Design and Procedures 
The NIMH Genetics Initiative Bipolar Project was active from 1989 -2007. This article 
uses data from probands and relatives assessed between 1998 and 2003 using the DIGS 3.0 
interview and resulting DSM-IV diagnoses. At each of 10 sites, multiplex families were 
ascertained through a proband and a first-degree relative, both with a DSM-IV diagnosis of BPI 
or Schizoaffective BP Type. (see diagnostic process in Supplementary Text, Section A). 
Diagnoses were coded as binary (0 = no, 1 = yes if “probable” or “definite”).  
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Statistical Methods 
 
The MPLUS software (Version 5.21) (Muthen and Muthen, 1998-2007) was used to 
perform CFA and CLCA on 1156 individuals (504 probands and 652 relatives) with BPI disorder 
using the COMPLEX option to account for the relatedness of individuals within families. 
Criteria of good overall CFA model fit were the following: comparative fit index (CFI) > .95 (Hu 
and Bentler, 1999), root mean square error of approximation (RMSEA) < .06 (Hu and Bentler, 
1999), and weighted root mean square residual (WRMR) < 1.00 (Yu, 2002). Loadings above 
0.40 indicated adequate fit for individual paths (Nunnally and Bernstein, 1994). We tested (two-
sided, 0.05 alpha) whether fit of the CFA model could be improved by adding or removing paths 
(see Supplementary Text, Section C). The robust weighted least squares (WLSMV) estimator 
and the nonlinear probit link were specified for CFA models. For LCA and CLCA models, 
maximum likelihood with robust standard error (MLR) estimation was used. 
An important deterministic constraint in CLCA models is the hypothesized “zero” class 
for which the probabilities of endorsing all comorbid disorders are fixed to be zero (e.g., “pure 
BP” class) (Muthen and Asparouhov, 2006). Our BPI subtyping hypothesis required two other 
deterministic constraints: an “externalizing only” class for which the probabilities of endorsing 
the externalizing disorders were freely estimated and the probabilities of endorsing the 
internalizing disorders were fixed to zero, and an “internalizing only” class for which the 
probabilities of endorsing the internalizing disorders were freely estimated and the probabilities 
of endorsing the externalizing disorders were fixed to zero. To fix a probability to zero, the 
threshold of the disorder was constrained to equal 15, which, fixes the probability of disorder 
endorsement to a value extremely close to zero (Clark et al., 2013; Finch and Bronk, 2011). We 
hypothesized a “both class” of BP persons who have substantial probability of both internalizing 
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and externalizing lifetime disorders for which probabilities were freely estimated for all 
internalizing and externalizing disorders.  
Additionally, we used equality and inequality constraints to test two competing versions 
of the hypothesized 4-class CLCA model, which we specified a priori before analyses. In the 
“equality” model we used equality constraints to test the  hypothesis that the probabilities of the 
externalizing disorders were not statistically different for the “ both” class and the “externalizing 
only” class, and the probabilities of the internalizing disorders were not statistically different for 
the “both” class and the “internalizing only” class. In the “inequality” model, we hypothesized 
that the probabilities of the externalizing disorders were statistically greater for the “both” class 
than the “externalizing only” class, and the probabilities of the internalizing disorders were 
statistically greater for the “both” class than the “internalizing class”. Further discussion of the 
equality and inequality hypotheses is contained in Section B of Supplementary Text. These two 
competing 4-class CLCA models amount to specifying a priori a small specific slice of the 
universe of possible equality and inequality constraints, deterministic constraints, and number of 
classes. 
The fit of CLCA and LCA models were evaluated based on the following criteria. 
Models with the lowest values for the Bayesian Information Criteria (BIC), and its sample size 
adjusted version (aBIC), were considered the best (Lubke and Muthén, 2005). The BIC and aBIC 
was used to compare different models with different number of classes and or parameterizations 
(Finch and Bronk, 2011). The likelihood ratio test (LRT) was used to compare the hypothesized 
4-class CLCA models to the exploratory 4-class model, because the former is nested within the 
latter (Finch and Bronk, 2011). The LRT is not appropriate for comparing LCA models with 
differing number of classes (Lubke and Muthén, 2005). Therefore, the Lo-Mendell-Rubin (LMR) 
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(Lo et al., 2001) likelihood ratio test was used to compare nested LCA models that have differing 
number of classes but the same parameterization (e.g., our exploratory 1-, 2-, 3-, 4-, 5-, and 6-
class LCA models). The LMR p-value indicates whether a model with 1 fewer classes can be 
rejected in favor of the current model. Classes with a sparse number of persons are not 
practically meaningful (Lubke and Muthén, 2005). Therefore, we rejected models that included 
classes with a sample size representing less than 5% of the sample. Post-hoc modifications to the 
CLCA models were considered by inspecting graphs of the “profile” of estimated disorder 
probabilities for each of the four classes.  
Only the disorders that were diagnosed in at least 50 BPI participants were included as 
individual variables in the CFA and CLCA models to ensure estimation precision. Some 
clinically similar disorders (e.g., panic disorder with and without agoraphobia) were combined 
because, if not combined, diagnostic mutual exclusion would have prevented them from loading 
on the same factor. The combined variables were coded “1” if any of the contributing diagnoses 
were “1” (probable or definite), and 0 otherwise. 
In addition, clinical judgments regarding a priori factor assignment of each variable in 
the hypothesized CFA model were made based on the relative importance of internalizing and 
externalizing symptoms for various disorders. The internalizing factor consisted largely of 
anxiety disorders, and the externalizing factor consisted largely of drug and alcohol use 
disorders. Due to sparseness of somatoform disorders, we decided a priori to include somatoform 
disorders and eating disorders in one variable, which we hypothesized to be explained by the 
internalizing factor (see Table 1).  
The factor scores and subject clusters for the 1156 BPI individuals were validated by 
testing their associations with clinical course variables known to be related to prognosis, 
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severity, and impairment (see Table 2 footnote for definitions). In each model, a clinical course 
variable was the dependent variable. The independent variables were the factors or clusters, 
adjusted for gender of BPI subject. Linear and logistic regression models were estimated using 
the SAS generalized linear modeling (GENMOD) procedure with the “generalized estimating 
equations” (GEE) (Liang and Zeger, 1986) estimation method to account for within-family 
correlations. For continuous outcomes, rank scores (robust to skewness) of the outcome, the 
normal error distribution, and the linear link were specified. For binary outcomes, the binomial 
error distribution and the exchangeable log odds ratio regression structure were specified. 
For the familial analysis, only first-degree relatives were included. Four clusters of 
probands were compared on binary disorders of relatives using GEE with GENMOD, as 
described above, and on an unordered eight-category dependent variable (eight clusters in 
relatives) using the SAS SURVEYLOGISTIC procedure, to account for within-family 
correlations. The familial models were adjusted for gender and age of relatives.  
All tests were two-sided with alpha of .05. Post-hoc pairwise comparisons were tested 
only if the omnibus test was significant (i.e., the protected version of Fisher’s Least Significant 
Difference). 
 
RESULTS 
Participant characteristics 
The 504 probands (from 504 multiplex families) with BPI disorder (96%) or 
schizoaffective BP type (4%) were adults; age at interview ranged from 18 to 88 (except one was 
age 17). The 1157 first-degree relatives of the 504 probands included mostly adults (range 18-
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93) with only eight (1%) adolescents (range 13-17). The high percentage of first-degree relatives 
with BPI or schizoaffective BP type (48.6%) was a function of multiplex family ascertainment. 
The main analyses (i.e., testing CFA and CLCA hypotheses and validating against 
clinical course variables) were based on 1156 persons with BPI disorder or schizoaffective BP 
type (504 adult probands; 594 first-degree relatives; and 58 more distant relatives) 
(Supplementary Table S1). At time of interview, 44% of those with BPI were married. Their 
median age of onset was 18.0. A majority was female and Caucasian. Prevalence of comorbid 
lifetime disorders is shown in Supplementary Table S1. 
 
Test of the confirmatory factor analysis (CFA) model 
All variables demonstrated large standardized factor loadings (0.50 or greater) on their 
hypothesized factor (Table 1). The CFA model demonstrated excellent fit to the data (CFI = 
1.000, RMSEA = 0.000, and WRMR = .556). The null hypothesis of good fit was not rejected by 
the chi-square goodness of fit test (chi-square = 9.29, df = 11, p = 0.60). The two factors were 
significantly correlated as hypothesized (r = .34, p < .001). A one-factor model showed poor fit 
(CFI = .76; RMSEA = .094; WRMR = 1.65; chi-square = 156.63, df = 14, p < .001). No 
statistically significant improvement upon the two-factor model could be found by adding or 
deleting paths. The eigenvalues further supported a two-factor solution (see Supplementary Text, 
Section D).  
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Associations Between Factors and Clinical Course Variables  
Comparison of factor scoring methods 
Validation with clinical course variables was initially performed for both the CFA-
coefficient-weighted factor scores and the commonly-used sum scale score (1 point for each 
variable). Results were similar for the two methods (Supplementary Table S2). Therefore, 
validation results are reported next using the sum score because it can be easily computed by 
hand during clinical encounters and it lent itself to disseminating dose-response relationships 
according to three clinically sensible categories: 0 disorders, 1 variable, and 2 or more variables 
(frequencies with 3 or 4 variables were sparse).  
Associations between factors and clinical course variables 
A significant association with internalizing and externalizing sum scores was observed 
for a majority of the clinical course variables (Table 2). A complete dose-response relationship 
was observed for age of onset, episode frequency, gender, and rapid switching, particularly for 
the internalizing score (all pairwise differences were significant). In addition, for inter-episode 
GAS score, disability, history of psychotic symptoms, and mixed states, one or two of the 
pairwise differences were significant and the means and percentages of clinical course variables 
generally showed dose-response trends (Table 2).  
There were no significant interactions between the internalizing and externalizing sum 
scores, except for mixed states (p = .029). Thus, the relationship with clinical course for one 
factor generally did not depend on whether participants scored low or high on the other factor.  
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Test of the Confirmatory Latent Class Analysis (CLCA) model 
The fit of the hypothesized CLCA model was compared to a wide range of exploratory 
LCA models and post-hoc modified CLCA models to strongly test its resilience (Table 3). Both 
alternatives of the hypothesized CLCA model (models #1 and #2) fit better (lower BIC and 
aBIC) than all exploratory (1-class through 6-class) models (models #3 through #8). The 5-class 
and 6-class exploratory models were not meaningful due to one or more classes having only 1% 
membership. The hypothesized CLCA model with full equality constraints (model #1) fit the 
best; its fit was slightly better than the competing CLCA model with full inequality constraints 
(model #2) and also better than all post-hoc modified CLCA models (models #9 through #16). 
Further non-essential description of CLCA results in Table 3 is provided in 
Supplementary Text, Section D. In summary, none of the post-hoc modified 4-class CLCA 
models or any of the 1-class through 6-class exploratory LCA models fit better than the CLCA 
model that was hypothesized to have deterministic constraints and full equality constraints 
(model #1). 
Associations between CLCA-derived BPI subtypes and clinical course variables 
BPI subtypes, based on most likely class membership from the best CLCA model (model 
#1), were compared on clinical course variables. Significant associations were found for 7 of the 
12 clinical course variables and in the anticipated directions (Table 4). For example, the median 
age of onset of major affective disorder was highest for those with no comorbid disorders (19.0) 
and lowest for those with both internalizing and externalizing variables (16.0). All pairwise 
differences were significant for age of onset except for the difference between “internalizing 
only” and “externalizing only” classes. The presence of internalizing disorders, either alone or in 
combination with externalizing disorders, was associated with greater episode frequency and 
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lower GAS score. Persons in class 1 (pure BPI without comorbidity) were less likely to have a 
history of psychotic symptoms than persons with externalizing disorders only (class 3) or 
persons with both internalizing and externalizing disorders (class 4). All three groups of BPI 
individuals with comorbidity had significantly greater history of rapid switching and mixed 
states than the cluster without comorbidity (class 1). Rapid switching was particularly elevated 
for the two clusters with internalizing disorders. 
Familial Analysis 
  There were eight possible comorbidity clusters of first-degree relatives defined by 
crossing the presence of BPI or other affective disorders with the four comorbidity classes that 
were defined for BPI probands from the best CLCA model. The four clusters of probands were 
significantly associated with the eight clusters of relatives, indicating significant familial 
aggregation of the hypothesized clusters after adjusting for gender and age of relatives (Table 5; 
4 × 8 omnibus test, p-value < .001). In particular, rates for three of the relative clusters differed 
between the four proband clusters (4 × 2 omnibus tests, p-value < .001, .045, and .001). 
Specifically, relatives were more likely to have pure affective disorder without other 
internalizing or externalizing disorders (36%) if their proband also had pure BPI (cluster 1). 
Relatives were also more likely to have affective disorder with both internalizing and 
externalizing disorders (17%) if the proband also had BPI with both internalizing and 
externalizing disorders (cluster 4). Finally, relatives were more likely to have affective disorders 
with other internalizing disorders and no externalizing disorders (18%) if the BPI proband also 
had internalizing disorders only (cluster 2), compared to relatives of pure BPI probands (cluster 
1) or BPI probands with externalizing disorders only (cluster 3). 
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The remaining familial analyses in Table 5 pertain to individual disorders. To summarize, 
several disorders and groups of disorders among the relatives differed significantly between the 
four proband clusters and in the anticipated directions (Table 5).   
  
DISCUSSION 
Synthesis of Findings 
The proposed two-factor CFA model showed an excellent fit to the data, suggesting inter-
correlated internalizing and externalizing comorbid factors in the context of BPI. Additional 
validity of the two-factor comorbidity model was supported by significant associations in 
anticipated directions between higher internalizing and externalizing factor scores and a majority 
of the clinical course variables that typically indicate worse prognosis, severity, and impairment. 
For the second set of analyses, the a priori hypothesized CLCA model with full equality 
constraints (model #1)  fit the data better than a range of 15 other models, including the 
competing hypothesized CLCA model with full inequality constraints, eight post-hoc 
modifications to both versions of the CLCA model, and six exploratory models. This best-fitting 
4-class model had a “zero”, “internalizing only”, “externalizing only”, and “both” class. The four 
subject clusters or BPI subtypes, based on the best fitting hypothesized CLCA model, 
demonstrated significant differences on a majority of the clinical course variables, supporting the 
meaningful interpretation of these subtypes. The findings from familial analysis offered further 
support for these four clusters of BPI individuals. 
A remarkable aspect about the results is the differences between “pure” BPI and BPI with 
any comorbidity. “Pure” BP runs in families, it has a later age of onset of major affective 
disorder in our data, generally lower episode frequency and less inter-episode impairment, fewer 
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psychotic symptoms, and less evidence of rapid switching and mixed states. That is, many of the 
“complications” of bipolar disorder that are typically regarded as evidence of more severe 
disorder, are differentially clustered in subjects with comorbid disorders. 
     More work is needed to evaluate whether the presence of comorbid anxiety disorders in 
children diagnosed with BP may be a marker of very early onset BP (Wozniak et al., 2002). Our 
findings suggest that the presence of either anxiety disorders (and/or other internalizing 
disorders) or externalizing disorders (such as substance use) is a marker of earlier onset of major 
affective disorder in adults diagnosed with BP.  
These features may be clearly noted in the two-factor validation findings as well. Here 
the “pure” subjects with zero trait presence on the factor score are seen to have later age of onset 
and fewer psychotic symptoms than those with any externalizing disorder, and lower episode 
frequency and evidence of mixed states than those with any internalizing disorder. 
The other remarkable aspect of this analysis is the “dose-response” demonstration that the 
presence of a greater number of comorbid disorders, either internalizing or externalizing, is 
associated with a distinct worsening of course of illness. This is particularly true with regard to 
the incidence of disability, poor interepisode functioning, rapid switching, and mixed states. The 
same pattern is seen in Table 4. Those subjects in the group with both externalizing and 
internalizing disorders are more symptomatic in multiple areas than subjects in the other clusters. 
Are subjects with only internalizing comorbid disorders different from subjects with only 
externalizing comorbid disorders? Firstly, they are more likely to be female (Table 4). Thus, it is 
important to emphasize that the comparisons of other clinical course variables in Tables 2 and 4, 
many of which were significant, were adjusted for gender.  
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Additionally, at least one externalizing disorder seems to have less of an impact on 
course of illness compared to having at least one internalizing disorder (consider episode 
frequency, interepisode GAS score, rapid switching and mixed states, all of which were different 
from “pure” BP in subjects with one internalizing disorder but not in those with one 
externalizing disorder; Table 2). A single externalizing disorder, on the other hand, is associated 
with an increased chance of psychotic symptoms, whereas having one or more internalizing 
disorders is not.  The familial analysis is notable in that alcohol and drug use disorders both 
aggregate in the relatives of subjects with externalizing disorders but not in the relatives of 
subjects without such disorders. 
The results here, using different statistical methods, are largely consistent with our 
previous results found in a high-risk study using a different data set entirely; specifically, two 
groups of childhood disorders (anxiety and externalizing) predicted subsequent major affective 
illness in adolescents of families with probands with adult BP disorder (Nurnberger et al., 2011). 
In the present study, the two same factors were shown through confirmatory tests of hypotheses 
to distinguish subtypes of adults with BPI. 
Numerous studies have used EFA and CFA to factor analyze symptoms of BP, including 
the symptoms or signs of mania (Bräunig et al., 1996; Faraone et al., 2004; Krüger et al., 2010; 
Perugi et al., 2001; Serretti et al., 1999), other mood or psychotic symptoms (Adida et al., 2008; 
Adler et al., 2008; Akiskal et al., 2001; Bauer et al., 1991; Berk et al., 2007; Cavanagh et al., 
2009; Daneluzzo et al., 2002; Dilsaver et al., 1999; Erkiran et al., 2008; González-Pinto et al., 
2003; Gupta et al., 2009; Harvey et al., 2008; Henry et al., 2007; Lindenmayer et al., 2008; 
Mitchell et al., 2013; Sato et al., 2002; Swann et al., 2001; Swann et al., 2008; Thompson et al., 
2010), cognitive and energy features (Cassano et al., 2009), temperament (Evans et al., 2005), 
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attention deficit hyperactivity disorder (ADHD) features (Joo et al., 2010), or childhood trauma 
signs (Garno et al., 2005). Resulting factors were shown to be modestly beneficial for genetic 
mapping in studies of BP, with respect to mood-disturbance factors (Faraone et al., 2004; Savitz 
et al., 2008), and an ADHD “inattention” factor (Joo et al., 2010). We anticipate that subtyping 
using clinical comorbidity will continue to shed light on the clinical and genetic characteristics of 
BPI.  
To date, there have been only four published studies using cluster-analysis or LCA 
among BPI patients to determine subtypes, all using the exploratory approach (Cassidy et al., 
2001; Dilsaver et al., 1999; Sato et al., 2002; Swann et al., 2001). These studies cluster-analyzed 
either the factor scores derived from the symptoms and behavioral ratings related to BPI or the 
symptoms and ratings themselves (Cassidy et al., 2001). Their results revealed more similarities 
than differences (Cassidy and Carroll, 2003; Sato et al., 2003). For example, all four studies 
found a pure (i.e., predominantly euphoric) subtype and a mixed (i.e., depressive or anxious-
depressive) subtype. Using a confirmatory approach applied to lifetime disorders, we found 
supporting evidence for a four-class lifetime comorbidity model in BPI individuals. A future 
CLCA on symptoms common to multiple comorbid disorders among BPI patients would add 
beneficial knowledge to the present CLCA findings of distinct lifetime comorbid disorders. 
In previous exploratory BPI cluster analyses, differences were found between clusters on 
acute pharmacological treatment response (Swann et al., 2002); masked independent clinical 
classification of mixed states but not on gender (Dilsaver et al., 1999); and gender, suicidality at 
admission, and social adjustment and residual symptoms at discharge, but not on age of onset 
(Sato et al., 2002). The present study, based on lifetime diagnoses instead of symptoms, 
established additional differences between classes that demonstrated confirmatory support.  It 
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should be noted that our sample size was larger, with more power to detect group differences on 
clinical course variables, than the previous studies which consisted of 105 (Dilsaver et al., 1999), 
162 (Swann et al., 2001), 327 (Cassidy et al., 2001), and 576 (Sato et al., 2002) BPI inpatients. 
 
Limitations 
It is possible that other variables not measured in the present study, such as traumatic 
stress, could improve the fit of the CFA and CLCA models. Medications could be a confounding 
or determining factor for clustering; however, the present dataset was not capable of addressing 
this issue. Test-retest reliability was not assessed for the comorbid disorders. This multiplex 
sample is highly familial and the results may or may not be applicable to sporadic BPI disorders.  
 
Conclusions 
There appears to be strong evidence for the two-factor and four-cluster lifetime 
comorbidity hypotheses. These hypotheses may be useful for understanding etiology and risk. 
The factors and clusters could be useful for parsimoniously reducing the number of variables in 
analyses of family, high-risk and case-control studies of persons living with BPI. These 
constructs may be useful for subtyping BP disorders and for prognosis by predicting course and 
severity of illness. Subtypes may also be useful for refining the phenotype in genetic studies. 
Subtypes may also have value for personalized medicine (Hamburg and Collins, 2010), assuming 
clinical subtypes could be linked to molecularly distinct subtypes, which may lead to new 
therapeutic possibilities, either through the development of targeted drugs or the salvaging of 
abandoned or failed drugs by identifying subgroups of patients likely to benefit from them.  
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Table 1. Confirmatory Factor Analysis (CFA) of Comorbid Lifetime Disorders from 1156 BPI Probands and BPI Relatives 
  
 
Number Loading SE z-value p-value 
Variables 
 
Factor 1 (Internalizing factor) 
    
 
1 
 
Panic, agoraphobia, anxiety NOS, GAD, PTSD 315 .81 .08 9.86 < .001 
2 
 
Any phobia disorder (specific or social) 164 .50 .06 9.35 < .001 
3 
 
Obsessive Compulsive disorder (OCD)        79 .55 .08 7.27 < .001 
4 
 
Any eating (anorexia, bulimia, NOS) or somatoform d/o 89 .55 .07 7.50 < .001 
Variables 
 
Factor 2 (Externalizing factor) 
 
    
5 
 
Any alcohol abuse or dependence                         444 .86 .07 13.30 < .001 
6 
 
Any drug abuse or dependence 329 .79 .06 14.11 < .001 
7 
 
Cluster B PD, impulse control, conduct d/o, ADHD 87 .50 .07 7.70 < .001 
        
  
Correlation between Factor 1 and Factor 2 
 
.34 .06 5.31 < .001 
   
Model fit 
    
Fit indices Chi-square test 
  
  CFI RMSEA WRMR 
Chi-square 
(df) p-value 
      1.000 0.000 0.556 9.29 (11) 0.60 
 
 
35 
 
Table 1, Continued 
     
Note. z-value = loading / standard error. d/o = disorder. NOS = not otherwise specified. GAD = generalized anxiety disorder. 
 
PTSD = post-traumatic stress disorder. ADHD = attention deficit hyperactivity disorder. 
   
Number = number of 1156 persons with presence (probable or definite) for each variable; each variable is defined as either  
 
an individual disorder (e.g., OCD) or presence of any disorder within a combination of disorders (e.g., any phobia disorder). 
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Table 2. Factors and Clinical Course of Illness Variables Among BPI Participants (BPI Probands and BPI Relatives)     
  
Factor 1 (Internalizing factor) 
 
Factor 2 (Externalizing factor)  
  
Factor score 
   
Factor score 
  
  
 
0 1 2, 3, or 4 
   
0 1 2 or 3     
Number of BPI participants: 
 
711 288 157 Omnibus Post-hoc 
 
609 274 273 Omnibus Post-hoc 
Factor score group number: 
 
(1) (2) (3) test pairwise 
 
(1) (2) (3) test pairwise 
Continuous Clinical Variables 
 
median median median p-value tests 
 
median median median p-value tests 
Age of onset 
 
19 17 15 *** ALL 
 
19 18 16 *** ALL 
Episode frequency per years ill 
 
0.43 0.57 0.87 *** ALL 
 
0.48 0.48 0.58 NS NA 
Mania/depression episode ratio 
 
1.00 0.80 1.00 NS NA 
 
1.00 1.00 1.00 NS NA 
Psychiatric hospitalizations per years ill 0.17 0.17 0.19 NS NA 
 
0.16 0.17 0.21 NS NA 
Between-episode GAS score 
 
70 65 61 *** (1)>(2)(3) 
 
70 70 61 *** (1)(2)>(3) 
Binary Clinical Variables (1=Yes, 0=No) n (%) n (%) n (%) 
   
n (%) n (%) n (%) 
  
Female 
 
55 69 81 *** ALL 
 
68 62 50 *** (1)(2)>(3) 
Disabled 
 
17 20 25 * (1)(2)<(3) 
 
17 17 25 * (1)(2)<(3) 
Psychotic symptoms 
 
47 52 62 NS (1)<(3) 
 
45 57 55 ** (1)<(2)(3) 
Mood incongruent psychotic symptoms 11 12 14 NS NA 
 
11 13 11 NS NA 
Rapid cycling 
 
9 10 13 NS NA 
 
8 10 13 NS NA 
Rapid switching 
 
39 53 71 *** ALL 
 
42 46 59 *** (1)(2)<(3) 
Mixed states   23 30 36 ** (1)<(2)(3)   23 27 34 ** (1)<(3) 
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Table 2, Continued, 
            
Note. Episode frequency = number of clean (i.e., episodes not likely to be caused by a specific organic factor, such as drug abuse, medication, 
or disease) affective episodes per years of illness. Mania/depression episode ratio = number of clean manic episodes over the number of clean 
depressive episodes. Psychiatric hospitalizations per years ill = number of hospitalizations divided by years of illness. Between-episode global 
assessment score (GAS) score = GAS score for the past month if not hospitalized, otherwise GAS score equals missing value.  
 
Disabled = occupationally disabled, from the present job question in DIGS 3.0. Presence of psychotic symptoms = at least one of five psychotic 
screening items in the DIGS 3.0 psychosis section definitely present and lasted persistently throughout the day for one day or intermittently for a 
period of three days. Mood-incongruent psychotic symptoms were present during either a mania or depression episode assessed in DIGS 3.0.  
Rapid cycling = four or more discrete episodes of mania or depression within 12 months demarcated by eight weeks or more of remission.  
Rapid switching = positive on the mania screening item in the DIGS mania section: “ever switched quickly from high to normal or high   
 
to depressed without normal mood between”. Mixed states = at least three symptoms of the opposite polarity lasting one week or more, plus 
positive on stem question “During this episode did you have a week or more during which your mood frequently changed between irritability or   
elation and sadness or depression?” in either the mania or depression sections of DIGS 3.0. NS = not significant. ALL = all three pairwise 
differences were significant. NA = post-hoc pairwise tests not applicable because omnibus test not significant. 
  
*p < .05, **p < .01, ***p < .001. The sum score, computed separately for internalizing and externalizing variables, was specified  in models as a  
categorical variable with three levels (0 disorders, 1 variable, 2 or more variables) because validation results were similar for sum scores and  
coefficient-weighted factor scores. Each row represents a different regression model (linear and logistic, respectively, for continuous and binary  
clinical course dependent variables), estimated using a generalized linear model (SAS GENMOD) with generalized estimating equations (GEE)  
to account for within-family correlations. 
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Table 3.  Confirmatory Latent Class Analysis (CLCA) of 7 Lifetime Comorbid Diagnostic Variables (N=1156 for All Models)   
Model No. of 
classes Log L 
No. free 
parms    
Most likely class membership size, n(%) 
# Constraints BIC aBIC LMR p 1 2 3 4 
 
Two competing CLCA models 
          
1 Zero-c, Int-only-c, Ext-only-c, Both-c, Full Eq 4 -3288 10 6647 6616 <.0001 422 (37) 187 (16) 289 (25) 258 (22) 
2 Zero-c, Int-only-c, Ext-only-c, Both-c, Full InEq 4 -3284 17 6687 6633 N/A 422 (37) 187 (16) 289 (25) 258 (22) 
 
Exploratory LCA models 
          
3 None 1 -3520 7 7089 7067 N/A 1156 (100) 
   
4 None 2 -3343 15 6791 6744 <.0001 389 (34) 767 (66) 
  
5 None 3 -3283 23 6727 6654 <.0001 101 (9) 725 (63) 330 (28) 
 
6 None 4 -3266 31 6751 6652 0.19 616 (53) 144 (12) 101 (9) 295 (26) 
7 None 5 -3259 39 6793 6669 0.13 7 (1) 124 (11) 376 (32) 102 (9) 
8 None 6 -3254 47 6840 6691 0.63 604 (52) 7 (1) 150 (13) 277 (24) 
 
Post-hoc modifications to CLCA models 
          
9 Model #1, except Eq(Int only) 4 -3285 13 6661 6619 <.0001 422 (37) 187 (16) 289 (25) 258 (22) 
10 Model #1, except Eq(Ext only) 4 -3288 14 6674 6629 <.0001 422 (37) 187 (16) 289 (25) 258 (22) 
11 Model #1, except Eq(Alc only) 4 -3285 12 6655 6617 <.0001 422 (37) 187 (16) 289 (25) 258 (22) 
12 Model #2, except InEq(Ext only) 4 -3284 17 6687 6633 N/A 422 (37) 187 (16) 289 (25) 258 (22) 
13 Model #1 or #2, except Eq(Int only) & InEq(Ext only) 4 -3285 13 6661 6619 N/A 422 (37) 187 (16) 277 (24) 270 (23) 
14 Model #1 or #2, except no Eq & no InEq constraints 4 -3284 17 6687 6633 <.0001 422 (37) 187 (16) 289 (25) 258 (22) 
15 Model #1, except Int-only+Alc-c 4 -3288 11 6655 6620 <.0001 422 (37) 187 (16) 289 (25) 258 (22) 
16 Zero-c, no other constraints 4 -3273 24 6715 6639 0.07 422 (36) 285 (25) 126 (11) 323 (28) 
 
 
39 
 
Table 3, Continued 
          
Note. No. = number. Int = internalizing. Ext = externalizing. Log L = Log Likelihood. No. free parms = Number of free parameters.  
  
Zero-c = zero-class specified by using a deterministic constraint to fix the probabilities of endorsing each of the 7 variables to be zero. 
 
Ext-only-c = externalizing-only class specified using a deterministic constraint to fix the probabilities of endorsing internalizing disorders to be zero. 
Int-only-c = internalizing-only class specified using a deterministic constraint to fix the probabilities of endorsing externalizing disorders to be zero. 
Both-c = both-class specified by allowing all probabilities for endorsing the 4 internalizing and the 3 externalizing variables to be freely estimated. 
 
Full Eq = full equality constraints in which endorsement probabilities of externalizing variables were constrained to be equal for the externalizing-only class 
and the both-class, and endorsement probabilities of internalizing variables were constrained to be equal for the internalizing-only class and the both-class. 
Full InEq = full inequality constraints in which endorsement probabilities of externalizing variables were constrained to be less for the externalizing-only class 
than the both-class, and endorsement probabilities of internalizing variables were constrained to be less for the internalizing-only class than the both-class. 
Eq(Int only), Eq(Ext only), Eq(Alc only) = instead of full equality constraints on all variables, the equality constraint was placed on only  
 
the 4 internalizing variables, or only the 3 externalizing variables, or only the 1 alcohol variable, respectively. 
   
InEq(Ext only) = instead of full inequality constraints on all variables, the inequality constraint was placed on only the 3 externalizing variables. 
 
Int-only+Alc-c = instead of an internalizing-only class, an internalizing-only-plus-alcohol class was specified using a deterministic constraint to fix 
the probabilities of endorsing externalizing disorders to be zero except for one externalizing variable, alcohol abuse or dependence disorders, for which 
the probability of endorsement was allowed to be freely estimated along with the internalizing disorders. BIC = Bayesian Information Criterion.  
aBIC = Sample size adjusted BIC. LMR p = Lo-Mendell Rubin test p-value. N/A = LRM test not available for models with (nonlinear) inequality constraints and  
not applicable for an exploratory model with 1 class. The most likely class membership size was 547 (47%) for class 5 for model #7,  
 
and were 17 (1%) and 101 (9%) for classes 5 and 6, respectively, for model #8. 
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Table 4. Clusters and Course of Illness Variables Among BPI Participants (BPI Probands and BPI Relatives)   
 
Clusters based on DSM-IV diagnosed co-morbid disorders 
  
 
None of the  Internalizing Externalizing Internalizing & 
  
  comorbid disorders d/o(s) only d/o(s) only Externalizing d/o(s) 
  Number of BPI probands  
& BPI relatives: 422 187 289 258 
 
Post-hoc 
Cluster group number: (1) (2) (3) (4) Omnibus pairwise comparisons 
Continuous Clinical Variables median median median median p-value between clusters 
Age of onset of major affective disorder 19.0 17.0 18.0 16.0 *** (1)>(2)(3)(4); (2)>(4); (3)>(4) 
Episode frequency per years ill 0.43 0.62 0.44 0.69 *** (1)<(2)(4); (2)>(3); (3)<(4) 
Manic/depressive episode ratio 1.00 0.75 1.00 1.00 NS NA 
Psychiatric hospitalizations per years ill 0.17 0.16 0.19 0.19 NS NA 
Between-episode GAS score 70 65 70 64 *** (1)>(2)(4); (3)>(4) 
Binary Clinical Variables (1=Yes, 0=No) n (%) n (%) n (%) n (%) 
  
Female 61 83 47 66 *** 
(1)<(2); (1)>(3); (2)>(3)(4); 
(3)<(4) 
Disabled 16 18 18 24 NS NA 
Psychotic symptoms 41 54 56 56 ** (1)<(3)(4) 
Mood incongruent psychotic symptoms 11 13 12 12 NS NA 
Rapid cycling 6 10 11 12 NS NA 
Rapid switching 34 59 46 60 *** (1)<(2)(3)(4); (3)<(4) 
Mixed states 19 33 30 32 *** (1)<(2)(3)(4) 
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Table 4, Continued 
      
Note. NS = not significant. NA = pairwise tests not applicable because omnibus test was not significant. *p < .05, **p < .01, ***p < .001. 
Each row represents a different regression model (linear and logistic, respectively, for continuous and binary clinical course dependent variables),  
estimated using a generalized linear model (SAS GENMOD) with generalized estimating equations (GEE) to account for within-family correlations.  
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Table 5. Familial Aggregation: Clusters and Disorders of First Degree Relatives (FDRs) by BPI Proband Clusters 
  Proband clusters based on DSM-IV co-morbid diagnoses 
        
 
None of the  Internalizing Externalizing Internalizing & 
  
Post-hoc 
 
comorbid d/o(s) d/o(s) only d/o(s) only Externalizing d/o(s) 
  
pairwise comparisons 
Cluster group number: (1) (2) (3) (4) 
  
between clusters 
Number in each BPI proband cluster: 177 79 121 127 
 
Omnibus (1) (1) (1) (2) (2) (3) 
Number of their FDRs: 406 171 301 279 
 
p-value (2) (3) (4) (3) (4) (4) 
 
Column % Column % Column % Column % 
        
Clusters in FDRs 
     
<.001 NS * * NS NS NS 
   No Affective d/o + No Int or Ext d/o 23 18 23 15 
 
.391 NA NA NA NA NA NA 
   No Affective d/o + Int d/o(s) only 3 2 2 2 
 
.768 NA NA NA NA NA NA 
   No Affective d/o + Ext d/o(s) only 7 4 11 8 
 
.110 NA NA NA NA NA NA 
   No Affective d/o + Int and Ext d/o(s) 1 2 3 3 
 
NA NA NA NA NA NA NA 
   Affective d/o      + No Int or Ext d/o 36 27 20 22 
 
<.001 * * * NS NS NS 
   Affective d/o      + Int d/o(s) only 9 18 9 14 
 
.045 * NS NS * NS NS 
   Affective d/o      + Ext d/o(s) only 16 17 20 19 
 
.169 NA NA NA NA NA NA 
   Affective d/o      + Int and Ext d/o(s) 6 13 14 17 
 
.001 NS * * NS NS NS 
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Table 5, Continued 
            
Affective disorders in FDRs Column % Column % Column % Column % 
        
   Bipolar d/o Type I (BPI)  49 53 46 48 
 
.652 NA NA NA NA NA NA 
   MDD recurrent (MDDR) 9 11 7 14 
 
.114 NA NA NA NA NA NA 
   Single episode MDD (SEMD) 5 4 5 6 
 
.753 NA NA NA NA NA NA 
   Any bipolar d/o NOS 2 5 1 3 
 
NA NA NA NA NA NA NA 
   Any depressive d/o NOS 4 4 3 6 
 
.436 NA NA NA NA NA NA 
   Any affective d/o 67 74 62 73 
 
.204 NA NA NA NA NA NA 
Internalizing disorders in FDRs 
            
  Anxiety disorders 
            
   Panic d/o without agoraphobia 5 14 13 13 
 
<.001 * * * NS NS NS 
   Panic d/o with agoraphobia 3 8 5 11 
 
.002 NS NS * NS NS * 
   Agoraphobia without panic attacks 2 1 1 2 
 
.770 NA NA NA NA NA NA 
   Anxiety d/o NOS 1 3 1 3 
 
.340 NA NA NA NA NA NA 
   Generalized anxiety d/o (GAD) 0 0 0.3 0 
 
NA NA NA NA NA NA NA 
   Post-traumatic stress d/o (PTSD) 0.3 1 1 1 
 
NA NA NA NA NA NA NA 
   Any anxiety d/o except phobia & OCD (v1) 11 25 19 27 
 
<.001 * * * NS NS NS 
   Social phobia  3 8 4 7 
 
.143 NA NA NA NA NA NA 
   Specific phobia 4 12 7 10 
 
.007 * NS * NS NS NS 
   Any phobia (v2) 7 16 10 16 
 
.003 * NS * NS NS * 
   OCD (v3) 2 10 2 3 
 
.036 * NS NS * * NS 
   Any anxiety disorders 16 34 26 34 
 
<.001 * * * NS NS NS 
   Somatization disorder 0.3 0 0.3 2 
 
NA NA NA NA NA NA NA 
   Any eating d/o 4 6 3 4 
 
NA NA NA NA NA NA NA 
   Any eating or somatoform d/o (v4) 4 6 3 6 
 
NA NA NA NA NA NA NA 
   Any Internalizing disorder 18 35 27 36 
 
<.001 * * * NS NS NS 
   Two, three or four internalizing variables 4 17 7 13 
 
<.001 * NS * * NS NS 
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Table 5, Continued 
            
Externalizing disorders in FDRs Column % Column % Column % Column % 
        
   Alcohol dependence 17 20 27 28 
 
.002 NS * * NS NS NS 
   Alcohol abuse 8 10 14 11 
 
.077 NA NA NA NA NA NA 
   Alcohol dependence or abuse (v5) 25 29 40 37 
 
<.001 NS * * * NS NS 
   Drug dependence 10 15 20 19 
 
.002 NS * * NS NS NS 
   Drug abuse 9 5 12 12 
 
.038 NS NS NS * * NS 
   Drug dependence or abuse (v6) 15 18 27 25 
 
<.001 NS * * * * NS 
   Any substance use disorder 29 34 47 45 
 
<.001 NS * * * * NS 
   Antisocial personality d/o (ASPD) 1 2 4 3 
 
.025 NS * * NS NS NS 
   Borderline personality d/o 0.3 0 0.3 0.4 
 
NA NA NA NA NA NA NA 
   Pathological gambling 1 2 1 3 
 
NA NA NA NA NA NA NA 
   Conduct d/o 1 2 4 1 
 
NA NA NA NA NA NA NA 
   Attention deficit hyperactivity d/o (ADHD) 0.5 0 0 1 
 
NA NA NA NA NA NA NA 
   Cluster B, impulse, conduct, ADHD (v7) 4 5 8 7 
 
.187 NA NA NA NA NA NA 
   Any Externalizing disorder 30 36 47 47 
 
<.001 NS * * * * NS 
   Two or three externalizing variables 12 15 21 20 
 
.001 NS * * * NS NS 
   Habitual smoking 33 26 35 42   .034 NS NS * NS * NS 
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Table 5, Continued 
            
Note. d/o = disorder. BPI = any BPI including BPI with mania and MDD, BPI manic never MDD, BPI mixed never manic, or schizoaffective bipolar.  
 
Int = internalizing. Ext = externalizing. MDD = major depressive d/o. The 7 variables (v1 to v7) in bold type face were defined a priori before analyses.  
The number of FDRs with BPI was mostly predetermined because BPI disorder in at least one FDR of each proband was an ascertainment criterion.  
Any bipolar d/o NOS = diagnosed with bipolar d/o NOS or bipolar II SEMD or cyclothymia or hypomania. 
        
Any depressive d/o NOS = diagnosed with depressive d/o NOS or dysthymia or adjustment d/o. 
         
An "NA" in the omnibus p-value column indicates that the models could not converge due to low prevalence of these disorders. 
      
In the first column, the rows with (v1), (v2), (v3), (v4), (v5), (v6), and (v7) represent the seven variables analyzed in the CFA and CLCA models. 
  
Each row represents a different logistic regression model, accounting for within-family correlations by using generalized estimating equations 
 
(GEE) (SAS GENMOD with GEE) for binary dependent variables and maximum likelihood estimation with variance adjustment based on the  
  
cluster structure (SAS SURVEYLOGISTIC) for the unordered eight-category dependent variable (eight clusters in relatives). 
   
 
 
 
 
   
Supplementary Table S1. Characteristics and Comorbid Disorders of 1156 BPI Participants
Participant Characteristics (n = 1156),    N   Min  Max  Mdn  Mean  SD 
Age at interview (years) 1121  14   89    42.0   42.4   12.5
                         [range] [18 - 89 (99.5%); 14-17 (n=6; 0.5%)]
Age of onset of major affective disorder 1141   5    75    18.0   19.6    8.3
Education (years) 1122   7    27    14.0   14.5    2.8
Episode frequency 1022   0    51      0.5    1.2    2.9  
Manic-depressive episode ratio  802    0    85     1.0     2.0    4.7
Hospitalizations per year  831    0     9      0.2     0.3    0.6
Between-episode GAS score  931   10  100   68.0   67.3   15.5
Number (column %)
Familial relationship (n = 1156)
  Proband 504 (43.6)
  First-degree relative 594 (51.4)
  Second-degree relative 16 (1.4)
  Relative, but not first or second degree 42 (3.6)
Female (n = 1155) 716 (62.0)
Disabled (n = 1124) 208 (18.5)
Ever psychosis symptoms (n = 1113) 560 (50.3)
Mood incongruent psychotic symptoms (n = 1111) 131 (11.8)
Rapid cycling (n = 1086) 103 (9.5)
Rapid switching (n = 1087) 510 (46.9)
Mixed states (n = 1111) 185 (16.7)
Supplementary Table S1, continued
Self-reported race/ethnicity (n = 1117) Number (column %)
  White (non-Hispanic) 1033 (92.5)
  Black (non-Hispanic) 32 (2.9)
  Hispanic 19 (1.7)
  American Indian/Alaskan Native 12 (1.1)
  Asian/Pacific Islander 2 (0.2)
  Other/Unknown 19 (1.7)
Marital Status (n = 1123)
  Married 491 (43.7)
  Never married 328 (29.2)
  Divorced 238 (21.2)
  Widowed 26 (2.3)
  Separated 40 (3.6)
DSM-IV disorders (n = 1156),
Major affective disorders
   Bipolar I with mania and major depressive disorder (MDD) 1031 (89.2)
   Bipolar I manic, never MDD 45 (3.9)
   Bipolar I mixed, never manic 27 (2.3)
   Schizoaffective bipolar type 53 (4.6)
Anxiety disorders
   Panic disorder without agoraphobia 163 (14.1)
   Panic disorder with agoraphobia 115 (10.0)
   Agoraphobia without panic attacks 27 (2.3)
   Anxiety disorder NOS 25 (2.2)
Supplementary Table S1, continued
Anxiety disorders, continued Number (column %)
   Generalized anxiety disorder (GAD) 4 (0.4)
   Post traumatic stress disorder (PTSD) 15 (1.3)
   Any panic or other anxiety disorders except OCD or phobias 418 (36.2)
   Obsessive compulsive disorder (OCD) 79 (6.8)
   Social phobia disorder 82 (7.1)
   Specific phobia disorder 106 (9.2)
Eating disorders
   Anorexia 30 (2.6)
   Bulimia 51 (4.4)
   Eating disorder NOS 15 (1.3)
   Any eating disorder 83 (7.2)
Somatoform disorders
   Conversion disorder 1 (0.1)
   Somatization disorder 6 (0.5)
Substance use disorders
   Alcohol dependence or abuse 444 (38.4)
   Drug dependence or abuse 329 (28.5)
   Any substance use disorder 529 (45.8)
Cluster B Personality disorders
   Anti-social personality disorder (ASPD) 43 (3.7)
   Borderline disorder 4 (0.4)
Supplementary Table S1, continued
Impulse control disorders Number (column %)
   Pathological gambling 21 (1.8)
   Kleptomania 1 (0.1)
   Impulse control disorder NOS 2 (0.2)
Attention-deficit and disruptive behavior disorders 
   Conduct disorder 23 (2.0)
   Attention-deficit/hyperactivity disorder (ADHD) 7 (0.6)
Note. BP = Bipolar. Mdn = Median. NOS = not otherwise specified.
Race/ethnicity was self-reported using options defined by the investigators.
Supplementary Table S2. Validation of Coefficient-Weighted Versus Sum Factor Scores
 Model Sum Model Sum
Number of BPI participants: 1156 1156 1156 1156
Continuous Clinical Variables r-sp r-sp r-sp r-sp
Age of onset -.28*** -.24*** -.27*** -.23***   
Episode frequency per years ill .16*** .16*** .09** .05  
Mania/depression episode ratio -.05 -.05 -.02 .02  
Psychiatric hospitalizations per years ill .03 .00 .07* .08*  
Between-episode GAS score -.19*** -.17*** -.18*** -.15***  
Binary Clinical Variables (1=Yes, 0=No)
Female .11** .19*** -.07* -.14***  
Disabled .09** .07* .08** .07*  
Psychotic symptoms .13** .10* .13*** .10**  
Mood incongruent psychotic symptoms .02 .02 .02 .01  
Rapid cycling .08* .05 .09** .08*   
Rapid switching .25*** .22*** .19*** .13***  
Mixed states .14*** .11*** .13** .10*  
Note . r-sp = Spearman rank correlation coefficient. "Model" columns = MPLUS factor score iteratively estimated 
from CFA model using WLSMV estimation. "Sum" columns = sum score based on sum of 0/1 variable scores. 
The clinical course of illness variables are explained in the footnote of Table 3. 
*p < .05, **p < .01, ***p < .001.
Factor 2 (Externalizing factor)Factor 1 (Internalizing factor)
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Supplementary Text. Additional Background, Methods, and Results 
 
A. Details regarding the diagnostic process 
 
Further details about the study design and procedures 
For the NIMH Genetics Initiative Bipolar Project, all diagnostic data and DNA has been 
deposited with the NIMH repository and is publicly available (zork.wustl.edu). In 2007 the 
collaborating groups formed the Bipolar Genome Study (BiGS), which is currently involved in 
sequencing studies based partially on the sample described here. 
 
DIGS Structured Interview 
The DIGS interview (Nurnberger et al., 1994) was developed as part of the NIMH 
Genetics Initiative. In 1998 the DIGS was revised (DIGS 3.0) to collect additional data on 
multiple episodes of mania, depression, self-injurious behavior, and drug use including tobacco 
use. Unipolar and BP affective disorders were fully assessed as were phenomenology such as age 
of onset, number of episodes, irritability, mixed states, and suicidal ideation or behavior.  A 
complete lifetime psychiatric history was obtained from each participant (probands and 
relatives). This history covered psychotic disorders, anxiety disorders, substance dependence 
(alcohol, nicotine, and illicit drugs), and an assessment of childhood and adult attention deficit 
symptoms. Habitual smoking was defined as smoking one pack per day or more for at least six 
months, either currently or in the past (Culverhouse et al., 2005). 
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Family History Assessment and Medical Records 
A structured family history assessment, the FIGS (available at zork.wustl.edu), was 
administered to all probands and relatives to obtain information on affective disorders in first-
degree relatives. Some participants were described by multiple FIGS assessments and all 
assessments were included in the best estimate diagnostic package. Medical records were 
requested for all participants who had mental health treatment. 
 
Diagnostic Procedures 
First, the interviewer assigned a clinical diagnosis after reviewing and editing the DIGS 
and writing a narrative summary. Second, an editor (normally the study coordinator) examined 
the DIGS for missing data and inconsistencies. The best-estimate package included the DIGS 
narrative summary, FIGS family history information, and medical records. Next, a senior 
clinician (most were MD psychiatrists) reviewed all available information in the package and 
assigned best estimate diagnoses. A second clinician reviewed the package independently. The 
diagnoses of the two clinicians were compared and discrepancies were resolved by 
discussion. Non-resolved cases were referred to a tiebreaker clinician who determined the final 
diagnoses. Test-retest reliability coefficients for the major affective diagnoses were greater than 
0.70 (Nurnberger et al., 1994). Age of onset was defined as age at first diagnosis for each of the 
comorbid disorders and age at first diagnosis with any major affective disorder (except 
hypomania) for the major affective disorders.   
 
Interviewer Training and Quality Assurance   
Interviewers were trained to administer the DIGS. Study participants were recontacted as 
needed to complete questions. Senior editors at each site reviewed all interviews for 
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completeness and accuracy. They also regularly met with principal investigators to resolve 
difficult questions regarding interviews and to ensure consistency of data across all sites.  
 
B. A brief introduction to CFA and CLCA in the context of the present paper 
Both categorical (i.e., different aggregations of symptoms are considered distinct 
dichotomous disorders) and dimensional (i.e., symptoms common to different disorders are 
considered dimensions that span categorical diagnoses) models of BPI provide insights into 
pathophysiology (Akiskal, 1983; Ketter et al., 2004). An analysis of symptoms common to 
different comorbid disorders in BPI persons is consistent with the dimensional viewpoint and 
acknowledges the complexity and heterogeneity of disorders (Kendell and Jablensky, 2003). The 
lifetime comorbid disorder strategy offers clinical utility and accounts for the longitudinal course 
of illness rather than specific episodes and thus provides a way to subdivide BP by trait as 
opposed to state characteristics. This paper uses the lifetime disorder approach for the factor and 
latent class analyses because it has received much less attention than the episodic symptom 
approach in prior factor and cluster analysis studies of comorbidity in BPI. 
Exploratory factor analysis (EFA) is used to explore the sample data to determine the 
minimum number of factors needed to parsimoniously explain the correlations among observed 
comorbid disorders and to determine which variables cluster together into (i.e., have regression 
coefficients that “load high on”) each factor. Confirmatory factor analysis (CFA) is used to test a 
priori hypotheses regarding the number of factors and the “assignment” of each variable to a 
factor. Variables are typically assigned to each factor by allowing, separately for each variable, 
the standardized coefficient or “loading” for the paths from the factors to be estimated for only 
one factor and to be fixed to zero for the other factors.  
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Observed cluster analysis or latent class analysis (LCA) can be used to identify subtypes 
of persons based on defined characteristics. LCA is a latent-variable approach to cluster analysis 
in which the measurement error involved with identifying latent (unobserved) clusters (i.e., 
classes) is accounted for in the analysis. The classes are based on the profile of the probabilities 
of endorsing each salient characteristic (in this case the comorbid disorders). In the LCA model, 
the prevalence or proportion of each latent class is estimated. Each person’s probability of 
membership in each class is estimated and used to classify them into their most likely group 
membership. 
CLCA is performed by specifying and testing specific hypotheses, expressed as a set of 
parameter constraints, regarding the number of latent classes and the relationship between the 
observed characteristics and the latent factors (Finch and Bronk, 2011). We used all three types 
of model constraints: deterministic, equality, and inequality constraints (Finch and Bronk, 2011). 
In CLCA, fit statistics are used to compare one or more hypothesized models with exploratory 
LCA models using a clinically relevant range of number of classes, and with other potential post-
hoc modifications of the hypothesized model (Finch and Bronk, 2011).   
We are not aware of published work that has tested, within BPI patients, the equality and 
inequality hypotheses, which we specified and tested in the two versions of the CLCA model. 
However, there is some minor evidence for the plausibility of those hypotheses. For example, in 
the Yale Family Study, relatives of probands diagnosed with both alcohol dependence and 
anxiety disorders had a trend for slightly higher alcohol dependence (20%) compared to relatives 
of probands with only alcohol dependence (15%) but had no elevated rate for anxiety disorders 
compared to relatives of probands with only anxiety disorders (19% vs 21%, respectively) 
(Merikanagas et al., 1996; Merikangas et al., May 1996). 
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However, we did not hypothesize what we felt to be unreasonable inequality hypotheses. 
For example, we did not hypothesize that the probabilities of externalizing and internalizing 
disorders in relatives would be less in the "both" class versus the externalizing or internalizing 
only classes. By choosing constraints for the hypothesized CLCA model, such as deterministic, 
and equality or inequality, we were able to hypothesize and test two alternatives (a particular 
equality constraint vs a particular inequality constraint) of a  very specific model (4-class model 
with deterministic constraints) within a much larger universe of possible models and then 
compare the hypothesized model to many other possible exploratory models and other models 
with post-hoc modifications of the hypothesized model.  
 
C. Tests of modification indices for CFA results 
A two-sided 0.05 alpha level was used to test whether a path in the CFA model should be 
added (using MPLUS modification indices) or removed (using a manual routine). An alpha of 
0.05 for tests of modification indices represents a robust test of the hypothesized model because 
“p < 0.05” is a rigorous decision rule for rejecting the null hypothesis of good fit for individual 
paths in a hypothesized CFA model and subsequently modifying the confirmatory model based 
on sample data. Practitioners of CFA often recommend using 0.01 alpha for determining whether 
to modify (add or delete) individual paths to avoid over-fitting by capitalizing on chance error in 
the sample data. 
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D. Additional results 
 
Model stability 
In all CLCA and LCA models, the maximum (i.e., best) log likelihood value was 
replicated for multiple sets of starting values, indicating good model stability. We attempted to 
estimate factor mixture models which combines CFA and CLCA models into a single model 
(Muthén, 2008); however, convergence was not achieved which is not uncommon for binary 
variables. 
 
Additional results to accompany the CFA findings 
Because the fit of the two-factor CFA model was extremely good, this suggests that a 
model with three or more factors would add very little additional benefit. To determine whether 
the sample data also suggests only two factors, the eigenvalues were inspected. The scree plot 
(not shown) of the eigenvalues indicated that there were two dominant factors and not more than 
two, because the decreases between eigenvalues became much smaller starting with the third 
eigenvalue: 2.59, 1.55, 0.73, 0.71, 0.62, 0.50, and 0.31. 
 
Additional description of results of CLCA and LCA from Table 4 
The 3-factor exploratory LCA model fit significantly better than the 2-factor exploratory 
LCA model (LRM, p < .0001). The 4-factor exploratory LCA model was not a significant 
improvement over the 3-factor exploratory LCA model (LMR, p = 0.19), and which of those 
models (3-factor or 4-factor exploratory) was preferred depended on whether the BIC or aBIC 
was used. However, according to the BIC and aBIC, both of the competing and a priori 
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hypothesized 4-factor CLCA models fit better than any exploratory LCA model, including the 2-
factor, 3-factor and 4-factor exploratory LCA models.  
Post-hoc inspection of parameter estimates and graphical output were used to determine 
whether the fit of the hypothesized CLCA models could be improved. In models #9 through #14, 
the same deterministic constraints were used as in models #1and #2 but the equality or inequality 
constraints were relaxed instead of using full equality constraints. Equality constraints were 
attempted for only the internalizing disorders (model #9) or only the externalizing disorders 
(model #10) or only alcohol (model #11). Inequality constraints were attempted for only the 
externalizing disorders (model #12). Equality constraints were specified for only the 
internalizing disorders and inequality constraints were specified for only the externalizing 
disorders (model #13).  In model #14, no equality or inequality constraints were applied.  
In models #15 and #16, the deterministic constraints were modified. Instead of an 
“internalizing only” class, model #15 allowed an “internalizing-only-plus-alcohol” class in 
which the externalizing variables were fixed to zero except for one externalizing variable, 
alcohol, for which a non-zero probability of endorsement was allowed to be estimated along with 
the internalizing disorders. In model #16, the zero-class or “pure BP” was the only deterministic 
constraint; in other words, all disorders were allowed to be estimated with non-zero probability 
for all of the three other classes. 
The estimable LMR tests showed that the 4-factor CLCA models (#1, #2), and their post-
hoc modifications (#9, #10, #11, #14, #15), were significantly better (p < .0001) fits to the data 
than a similarly constrained 3-factor model. The use of only a “zero” class for deterministic 
constraints was not statistically better than a 3-class model with a similar constraint (model #16, 
8 
 
LMR, p = .07).  However, none of the post-hoc modified models fit better than the hypothesized 
CLCA model with deterministic constraints and full equality constraints (model #1).  
 
Sensitivity analysis 
Habitual smoking is different from other substance use disorders in its social and legal 
aspects. Therefore, although habitual smoking was reported as one of the individual outcome 
variables among first-degree relatives in the familial analysis, habitual smoking was excluded 
from the hypothesized two-factor model and the four-cluster model and from the CFA and 
CLCA models used to test these hypotheses. However, as a sensitivity analysis, re-estimation of 
CFA and CLCA models were conducted after including habitual smoking as a fourth indicator of 
the externalizing factor. Habitual smoking was defined as smoking one pack per day or more for 
at least six months, either currently or in the past (Culverhouse et al., 2005). Results showed 
approximately similar (i.e., good) fit as the CFA and CLCA models that we reported which 
excluded smoking. However, the factor and class associations with the clinical course variables 
were not as strong when habitual smoking was included. 
In another sensitivity analysis, the CFA and CLCA analyses were re-run after excluding 
the sparsest disorders: generalized anxiety disorder (GAD), post-traumatic stress disorder 
(PTSD), somatoform disorders, impulse control disorders, conduct disorder and  
attention deficit hyperactivity disorder (ADHD).  Results were very similar to those reported in 
this paper. 
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